Abstract:Objective: In this study, we aimed to investigate the differences in serum lipid metabolite profiles and their relationship with clinical characteristics between patients with eosinophilic and non-eosinophilic AECOPD. Methods: A total of 71 AECOPD patients were enrolled. Eosinophilic AECOPD was defined as blood EOS% ≥ 2% (n = 23), while non-eosinophilic AECOPD, as blood EOS< 2% (n = 48). Clinical data were collected, and serum lipid metabolism profiles were detected by liquid chromatography-mass spectrometry (LC-MS). The XCMS software package was used to pre-process the raw data, and then, lipid metabolite identification was achieved through a spectral match using LipidBlast library. Differences in lipid profiles and clinical features between eosinophilic and non-eosinophilic groups were analyzed by generalized linear regression. The least absolute shrinkage and selection operator (LASSO) was applied to screen the most characteristic lipid markers for the eosinophilic phenotype. Results: Eosinophilic AECOPD patients had less hypercapnic respiratory failures, less ICU admissions, a shorter length of stay in the hospital, and a lower fibrinogen level. In the lipid metabolism profiles, 32 significantly different lipid metabolites were screened through a t-test adjusted by using FDR (FDR-adjusted p < 0.05 and VIP> 1). Nine differential lipid metabolites were found to be associated with the three clinical features, namely, hypercapnia respiratory failure, ICU admission, and fibrinogen in further integration analysis. The species of triacylglycerol (TAG), phosphatidylcholine (PC), lysophosphatidylcholine (LPC), and diacylglyceryl trimethylhomoserine (DGTS) were high in these eosinophilic AECOPD. The LASSO was applied, and three lipid metabolites were retained, namely, LPC (16:0), TAG (17:0/17:2/17:2), and LPC (20:2). The logistic regression model was fitted using these three markers, and the area under the ROC curve of the model was 0.834 (95% CI: 0.740-0.929). Conclusion: Patients with eosinophilic AECOPD had a unique lipid metabolism status. Species of TAGs and LPCs were significantly increased in this phenotype and were associated with better clinical outcomes.

Dyslipidemia is Associated with Worse Asthma Clinical Outcomes: A Prospective Cohort Study.

Association of blood lipid profiles and asthma: A bidirectional two‐sample Mendelian randomization study

Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis

Stratification of asthma by lipidomic profiling of induced sputum supernatant

Clinical and Inflammatory Features of Exacerbation-Prone Asthma: A Cross-Sectional Study Using Multidimensional Assessment

Association Between Atopic Dermatitis, Asthma, and Serum Lipids: A UK Biobank Based Observational Study and Mendelian Randomization Analysis

Association between serum lipid and all-cause mortality in asthmatic populations: a cohort study

High Density Lipoprotein-Cholesterol is Inversely Associated with Blood Eosinophil Counts among Asthmatic Adults in the USA: NHANES 2011-2018.

Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study

Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease

Body Composition-Specific Asthma Phenotypes: Clinical Implications

Clinical Differences Between Early- and Late-Onset Asthma: A Population-Based Cross-Sectional Study

Homeostatic Measure of Insulin Resistance Is Associated With Future Asthma Exacerbations: A 1-Year Prospective Cohort Study

Association of Socioeconomic Status and a Broad Combination of Lifestyle Factors with Adult-Onset Asthma: a Cohort Study

Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis

Small Airway Dysfunction in Asthma is Associated with Perceived Respiratory Symptoms, Non-Type 2 Airway Inflammation, and Poor Responses to Therapy

Sputum Metabolomic Profiling Reveals Metabolic Pathways and Signatures Associated with Inflammatory Phenotypes in Patients with Asthma

Characteristics of Severe Asthma in China with One Year Follow-Up: the C-BIOPRED Study

Causal relationship between Lipdome and Chronic Obstructive Pulmonary Disease and Asthma: Mendelian randomization

Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes